Hui, L.-A.; Bodolea, C.; Popa, A.; Vlase, A.-M.; Hirișcău, E.I.; Vlase, L.
Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion. Antibiotics 2024, 13, 961.
https://doi.org/10.3390/antibiotics13100961
AMA Style
Hui L-A, Bodolea C, Popa A, Vlase A-M, Hirișcău EI, Vlase L.
Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion. Antibiotics. 2024; 13(10):961.
https://doi.org/10.3390/antibiotics13100961
Chicago/Turabian Style
Hui, Ligia-Ancuța, Constantin Bodolea, Adina Popa, Ana-Maria Vlase, Elisabeta Ioana Hirișcău, and Laurian Vlase.
2024. "Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion" Antibiotics 13, no. 10: 961.
https://doi.org/10.3390/antibiotics13100961
APA Style
Hui, L.-A., Bodolea, C., Popa, A., Vlase, A.-M., Hirișcău, E. I., & Vlase, L.
(2024). Linezolid Pharmacokinetics in Critically Ill Patients: Continuous Versus Intermittent Infusion. Antibiotics, 13(10), 961.
https://doi.org/10.3390/antibiotics13100961